P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

NCT06079775 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: Xeruborbactam Oral Prodrug
DRUG: Ceftibuten
DRUG: Xeruborbactam Oral Prodrug Placebo
DRUG: Ceftibuten Placebo

Sponsor

Qpex Biopharma, Inc.

Collaborators

[object Object]
[object Object]